Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Mucormycosis: Current Perspectives on Treatment, Diagnosis, and Advancements
View through CrossRef
Objective:
This review study examines mucormycosis treatment challenges, gaps in medicines,
and COVID-19-related effects. This paper examines diagnostic and drug development advances
while addressing safety and specificity.
Methods:
This review study searches PubMed, Web Science, and Scopus for relevant material.
Keywords associated with mucormycosis, therapy, diagnosis, medication advancement, and COVID-
19 are used to identify pertinent articles. Data extraction summarizes therapeutic obstacles, diagnostic
advances, and innovative drug options.
Results:
This review article covers mucormycosis therapy, diagnostics, and drug development. It
reveals limitations in present medicines, such as selectivity, safety, and resistance mechanisms. Diagnostic
advances and mucormycosis in COVID-19 have also been explored.
Conclusion:
This review emphasizes the need for more secure, specific mucormycosis therapies. It
discusses therapy obstacles, diagnostic advances, and new drug techniques. Overall, this research
emphasizes improving mucormycosis therapy to enhance patient outcomes.
Title: Mucormycosis: Current Perspectives on Treatment, Diagnosis, and Advancements
Description:
Objective:
This review study examines mucormycosis treatment challenges, gaps in medicines,
and COVID-19-related effects.
This paper examines diagnostic and drug development advances
while addressing safety and specificity.
Methods:
This review study searches PubMed, Web Science, and Scopus for relevant material.
Keywords associated with mucormycosis, therapy, diagnosis, medication advancement, and COVID-
19 are used to identify pertinent articles.
Data extraction summarizes therapeutic obstacles, diagnostic
advances, and innovative drug options.
Results:
This review article covers mucormycosis therapy, diagnostics, and drug development.
It
reveals limitations in present medicines, such as selectivity, safety, and resistance mechanisms.
Diagnostic
advances and mucormycosis in COVID-19 have also been explored.
Conclusion:
This review emphasizes the need for more secure, specific mucormycosis therapies.
It
discusses therapy obstacles, diagnostic advances, and new drug techniques.
Overall, this research
emphasizes improving mucormycosis therapy to enhance patient outcomes.
Related Results
Mucormycosis Research: A global outlook through bibliometric approaches
Mucormycosis Research: A global outlook through bibliometric approaches
Objective. Mucormycosis is a fungal infection in humans where the causative pathogens belong to the order of Mucorales. The fungal pathogens are also known as black fungi based on ...
Mucormycosis and role of clinical pharmacologist
Mucormycosis and role of clinical pharmacologist
Mucormycosis (zygomycosis) is a fungal infection (serious but rare) caused by a group of molds called mucoromycetes and it is considered the third most common invasive fungal disea...
MUCORMYCOSIS IN POSTCOVID ERA: DIAGNOSTIC AND THERAPEUTIC CHALLENGES
MUCORMYCOSIS IN POSTCOVID ERA: DIAGNOSTIC AND THERAPEUTIC CHALLENGES
Background : Mucormycosis, first identified in 1885, has surged in incidence, especially post-COVID-19, primarily
affecting immunocompromised individuals such as those with uncontr...
1703. Bacterial or Fungal Co-Infection in Patients with Mucormycosis
1703. Bacterial or Fungal Co-Infection in Patients with Mucormycosis
Abstract
Background
There is a growing concern on infections with multiple organisms including fungi in patients with mucormycos...
Rhinocerebral mucormycosis: A clinicopathological analysis of COVID-19-associated mucormycosis
Rhinocerebral mucormycosis: A clinicopathological analysis of COVID-19-associated mucormycosis
ABSTRACT
Background:
During the coronavirus disease 2019 (COVD-19) pandemic, the incidence of mucormycosis also increase...
AN EPIDEMIOLOGICAL STUDY ON POST-COVID MUCORMYCOSIS IN JAMNAGAR, GUJARAT
AN EPIDEMIOLOGICAL STUDY ON POST-COVID MUCORMYCOSIS IN JAMNAGAR, GUJARAT
Introduction: Covid19 predisposes to mucormycosis, probably due to diabetes, steroid and immunosuppressive status and is associated with high
morbidity and mortality. Present study...
Mucormycosis
Mucormycosis
Now a days during the pandemic condition such as Covid-19 Many fungal infections are happening to the peoples. Mucormycosis is one of the fungal infections which occurs in the pati...
Paraplegia secondary to disseminated mucormycosis: case report and literature review
Paraplegia secondary to disseminated mucormycosis: case report and literature review
Abstract
Background
We report a case of spine infection with mucormycosis that manifested signs of paraplegia in a patient suffering from disseminat...